CD274 and cancer: KEGG pathway enrichment revealed that these genes were primarily involved in T cell receptor signaling, chemokine signaling, B cell receptor signaling, PD-L1 expression, NF-κB signaling, and the PD-1 checkpoint pathway in cancer (Table 4).